U.S. Online Retail and Ecommerce Stock News

NasdaqGS:ATAT
NasdaqGS:ATATHospitality

November 2025's Top Value Picks For Potential Market Opportunities

As the U.S. stock market navigates a mixed landscape with tech shares rebounding and the Dow Jones Industrial Average experiencing declines, investors are closely watching for opportunities amid fluctuating indices. In this environment, identifying undervalued stocks becomes crucial, as they may present potential value plays despite broader market volatility and economic uncertainties.
OTCPK:RAAS.Y
OTCPK:RAAS.YSoftware

Natural Health Trends And 2 Other Penny Stocks With Promising Financials

The U.S. stock market has been experiencing mixed movements, with the Dow Jones Industrial Average declining for a second consecutive day while technology shares show signs of recovery. Amid these fluctuations, investors are often on the lookout for stocks that offer potential growth opportunities at lower price points. Penny stocks, though an older term, continue to represent a niche investment area where smaller or newer companies can shine. When these stocks boast strong financial health...
NYSEAM:BHB
NYSEAM:BHBBanks

Top 3 Dividend Stocks To Consider For Your Portfolio

As the U.S. stock market experiences mixed movements with technology shares rebounding and the Dow Jones Industrial Average declining for a second consecutive day, investors are closely watching economic indicators following a prolonged government shutdown. In such uncertain times, dividend stocks can provide a measure of stability and income, making them an attractive option for those looking to bolster their portfolios amidst fluctuating market conditions.
NasdaqCM:FTCI
NasdaqCM:FTCIElectrical

Can FTC Solar’s (FTCI) Rapid Sales Growth Outweigh Persistent Losses in Its Investment Story?

FTC Solar, Inc. recently announced its third quarter 2025 results, reporting revenue of US$26.03 million, up from US$10.14 million a year earlier, while net loss widened to US$23.94 million from US$15.36 million over the same period. Alongside the earnings announcement, the company set its fourth quarter 2025 revenue guidance between US$30.0 million and US$35.0 million, highlighting continued sales momentum despite persistent losses. We’ll explore how this combination of rapid revenue growth...
NasdaqCM:ENGN
NasdaqCM:ENGNBiotechs

enGene Holdings (ENGN) Valuation in Focus Following Promising Phase 2 Bladder Cancer Trial Results

enGene Holdings (ENGN) is drawing attention after announcing positive preliminary results from the pivotal cohort of its Phase 2 LEGEND trial. The data showed a high complete response rate and a favorable safety profile in challenging bladder cancer cases. See our latest analysis for enGene Holdings. enGene Holdings’ impressive momentum really kicked in after its recent LEGEND trial data sent the stock soaring, highlighted by a 40% seven-day share price return and a staggering 129% gain over...